Aerpio Pharmaceuticals, Inc.
TIE-2 ACTIVATORS TARGETING THE SCHLEMM'S CANAL
Last updated:
Abstract:
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for eye conditions, for example, intraocular pressure, ocular hypertension, and glaucoma.
Status:
Application
Type:
Utility
Filling date:
28 Apr 2020
Issue date:
29 Oct 2020